Role of central angiotensin receptors in scopolamine-induced impairment in memory, cerebral blood flow, and cholinergic function.

Psychopharmacology
Santoshkumar TotaChandishwar Nath

Abstract

Inhibition of renin-angiotensin system (RAS) improves cognitive functions in hypertensive patients. However, role of AT1 and AT2 receptors in memory impairment due to cholinergic hypofunction is unexplored. This study investigated the role of AT1 and AT2 receptors in cerebral blood flow (CBF), cholinergic neurotransmission, and cerebral energy metabolism in scopolamine-induced amnesic mice. Scopolamine was given to male Swiss albino mice to induce memory impairment tested in passive avoidance and Morris water maze tests after a week long administration of blocker of AT1 receptor, candesartan, and AT2 receptor, PD123, 319. CBF was measured by laser Doppler flowmetry. Biochemical and molecular studies were done in cortex and hippocampus of mice brain. Scopolamine caused memory impairment, reduced CBF, acetylcholine (ACh) level, elevated acetylcholinesterase (AChE) activity, and malondialdehyde (MDA). Administration of vehicle had no significant effect on any parameter in comparison to control. Candesartan prevented scopolamine-induced amnesia, restored CBF and ACh level, and decreased AChE activity and MDA level. In contrast, PD123, 319 was not effective. However, the effect of AT1 receptor blocker on memory, CBF, ACh level, and ...Continue Reading

References

Feb 1, 1975·Analytical Biochemistry·C Wang, R L Smith
Aug 1, 1990·Journal of Cardiovascular Pharmacology·J M BarnesT J Williams
Jan 1, 1991·Annals of the New York Academy of Sciences·R W JonesJ Kirby
Jan 1, 1990·Progress in Brain Research·E Giacobini
Oct 1, 1988·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·W G HonerL R Lucas
Jul 1, 1987·Pharmacology, Biochemistry, and Behavior·G Spignoli, G Pepeu
Oct 1, 1982·Analytical Biochemistry·L C GreenS R Tannenbaum
May 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·S E MolchanT Sunderland
Aug 1, 1993·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·K Plaschke, S Hoyer
Sep 1, 1993·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·M H BassantY Lamour
Nov 1, 1996·Biological Reviews of the Cambridge Philosophical Society·R MosimannD Felix
Jun 8, 2001·Journal of Cardiovascular Pharmacology·G Ertl, K Hu
Jun 20, 2001·American Journal of Hypertension·R M CareyH M Siragy
Mar 7, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·T M EstrupS Strandgaard
Mar 22, 2002·European Journal of Pharmacology·Paul R Gard
Jun 14, 2003·Journal of the Renin-angiotensin-aldosterone System : JRAAS·Patrick G Kehoe
May 1, 1959·Archives of Biochemistry and Biophysics·G L ELLMAN
Jul 1, 1961·Biochemical Pharmacology·G L ELLMANR M FEATHER-STONE
Apr 17, 2004·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Tobias EngelhornRainer Schulz
Jun 28, 2005·Current Alzheimer Research·Egemen Savaskan
Oct 3, 2006·Current Opinion in Neurobiology·Michael E Hasselmo
Mar 13, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Björn MaulThomas Walther
Sep 29, 2009·Experimental Neurology·John W Wright, Joseph W Harding
Oct 3, 2009·Trends in Neurosciences·Patrick G KehoeSeth Love

❮ Previous
Next ❯

Citations

Dec 12, 2012·Current Hypertension Reports·Claudia A McCarthyEmma S Jones
Jul 11, 2013·Behavioural Pharmacology·Shakti D PachauriChandishwar Nath
Jun 6, 2013·Clinical and Experimental Pharmacology & Physiology·Colin SumnersUlrike M Steckelings
Oct 1, 2013·Evidence-based Complementary and Alternative Medicine : ECAM·Subhash DwivediRakesh Shukla
Jan 28, 2014·Psychopharmacology·Shuichi YanaiShogo Endo
Jun 25, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Gali UmschweifEsther Shohami
May 23, 2014·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Gali UmschweifEsther Shohami
May 21, 2013·NeuroImage·O M DoyleA F Marquand
Jan 1, 2014·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Aliya AhmadVasudevan Mani
Aug 1, 2016·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Shan ZhuangCheng-Ming Xing
Nov 7, 2016·Regulatory Toxicology and Pharmacology : RTP·Bapi GorainTapan Kumar Pal
Nov 2, 2014·American Journal of Hypertension·Sonia Villapol, Juan M Saavedra
Jun 9, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jianbo ChenYinshi Sun
May 25, 2013·Current Opinion in Cardiology·Ihab Hajjar, Kathleen Rodgers
Jan 15, 2018·Pharmacological Reports : PR·Emil TrofimiukJan J Braszko

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

Basal Forebrain- Circuits

Basal forebrain is a region in the brain important for production of acetylcholine and is the major cholinergic output of the CNS. Discover the latest research on circuits in the basal forebrain here.

Anthelmintics

Anthelmintics or antihelminthics are a group of antiparasitic drugs that expel parasitic worms (helminths) and other internal parasites from the body by either stunning or killing them and without causing significant damage to the host. Discover the latest research on anthelmintics here.